Last 506.50 GBp
Change Today 0.00 / 0.00%
Volume 18.0
As of 11:35 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

immunodiagnostic systems hld (IDH) Snapshot

Open
506.50 GBp
Previous Close
506.50 GBp
Day High
506.50 GBp
Day Low
506.50 GBp
52 Week High
02/20/14 - 593.00 GBp
52 Week Low
04/17/13 - 324.00 GBp
Market Cap
147.7M
Average Volume 10 Days
10.2K
EPS TTM
0.24 GBp
Shares Outstanding
29.2M
EX-Date
07/24/13
P/E TM
21.5x
Dividend
3.33 GBp
Dividend Yield
0.66%
Current Stock Chart for IMMUNODIAGNOSTIC SYSTEMS HLD (IDH)

Related News

No related news articles were found.

immunodiagnostic systems hld (IDH) Related Businessweek News

No Related Businessweek News Found

immunodiagnostic systems hld (IDH) Details

Immunodiagnostic Systems Holdings PLC engages in the manufacture and distribution of medical diagnostic products in the United States, Europe, and internationally. It provides a range of manual and automated assays for use in the areas of bone and calcium metabolism, growth, hypertension, hypertension, and kidney diseases; and automated immunoassay system that offers a compact bench top system, which automates immunoassay testing. The company also provides Octeia and Gamma B products; and SBA - Trap kits, such as RatTrap, MouseTRAP, and human BoneTRAP products. It markets its products directly, as well as through distributors. The company is headquartered in Boldon, the United Kingdom.

307 Employees
Last Reported Date: 06/28/13

immunodiagnostic systems hld (IDH) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: 277.0K GBP
Group Finance Director and Director
Total Annual Compensation: 19.0K GBP
Executive Officer of North American Operation...
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

immunodiagnostic systems hld (IDH) Key Developments

Immunodiagnostic Systems Holdings plc Provides Earnings Guidance for the Year Ended March 31, 2014 and for the Year Fiscal Year 2015

Immunodiagnostic Systems Holdings plc provided earnings guidance for the year ended March 31, 2014 and for the year fiscal year 2015. For the year, the company’s total revenues are expected to be £52.3 million compared to £49.8 million reported in the year 2012-2013, representing 5% growth. The increase in revenue was primarily driven by the continued growth in automated revenue of 21%, compared to the prior year. Manual revenue declined by 18% over the same period. Adjusted EBIT, before exceptional items, is expected to be marginally ahead of the prior year adjusted EBIT compared to £9.8 million reported in the year 2012-2013. The company announced that execution of the strategic initiatives, the company expected to lead to continued modest revenue growth in 2014-2015 counteracted to some degree by the effect of operating cost investment made in 2013-2014.

Immunodiagnostic Systems Holdings plc Announces the Step Down of Burkhard Wittek from the Board

Immunodiagnostic Systems Holdings plc announced that Dr. Burkhard Wittek, a Non-Executive Director, stepped down from the Board with effect from March 6, 2014.

Immunodiagnostic Systems Holdings plc Announces FDA Clearance for Direct Renin Immunoassay

Immunodiagnostic Systems Holdings plc has received the FDA clearance for its Direct Renin assay for use on its IDS-iSYS system. The IDS-iSYS Direct Renin immunoassay is used to determine the amount of active renin present in the blood. Results of the test are used in conjunction with other clinical and laboratory data to assist clinicians in the investigation of hypertension related disorders such as primary aldosteronism and renovascular hypertension. The test enables the quantitative determination of renin in less than an hour, providing laboratories with a fast and reliable alternative to existing laborious manual methods, a necessity when screening in extended hypertensive populations.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDH:LN 506.50 GBp 0.00

IDH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IDH.
View Industry Companies
 

Industry Analysis

IDH

Industry Average

Valuation IDH Industry Range
Price/Earnings 22.7x
Price/Sales 2.9x
Price/Book 1.8x
Price/Cash Flow 22.8x
TEV/Sales 2.9x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNODIAGNOSTIC SYSTEMS HLD, please visit www.idsplc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.